Adverse Reaction to Drug Recruiting Phase Trials for Milnacipran (DB04896)

IndicationStatusPhase
DBCOND0042486 (Adverse Reaction to Drug)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00817375Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed PatientsTreatment